Physcion 8-O-β-D-glucopyranoside
CAS No. 23451-01-6
Physcion 8-O-β-D-glucopyranoside( Physcion 8-O-beta-D-monoglucoside )
Catalog No. M29212 CAS No. 23451-01-6
Physcion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 176 | Get Quote |
|
| 10MG | 266 | Get Quote |
|
| 25MG | 447 | Get Quote |
|
| 50MG | 651 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePhyscion 8-O-β-D-glucopyranoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionPhyscion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.
-
DescriptionPhyscion 8-O-β-D-glucopyranoside has anti-inflammatory and anti-cancer activities. Physcion 8-O-β-D-glucopyranoside can be used in studies about common malignancy cancer.(In Vitro):Physcion 8-O-β-D-glucopyranoside inhibits TNF-α±-induced cytotoxicity and apoptosis in L929 cells via TNF-R1.
-
In Vitro——
-
In Vivo——
-
SynonymsPhyscion 8-O-beta-D-monoglucoside
-
PathwayApoptosis
-
TargetTNF
-
RecptorTNF
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number23451-01-6
-
Formula Weight446.408
-
Molecular FormulaC22H22O10
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (56.00 mM)
-
SMILESCOc1cc(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)c2C(=O)c3c(O)cc(C)cc3C(=O)c2c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Zigakibart
Zigakibart (BION-1301) is a humanized monoclonal antibody targeting TNFSF13 with anti-inflammatory activity for the study of immunoglobulin A nephropathy (IgAN).
-
SPD304
SPD304 is a selective TNF-α inhibitor and blocks the interaction of TNF and its receptor. SPD304 has an IC50 of 22 μM for inhibiting in vitro TNF receptor 1 binding to TNF-α.
-
Ragifilimab
Ragifilimab (INCAGN-1876) is an agonist monoclonal antibody that targets glucocorticoid-induced TNFR-associated protein (GITR) and can be used in the study of advanced or metastatic solid tumors.
Cart
sales@molnova.com